Using biopolymers and taking a circular product design approach, Ypsomed has developed what it calls “the world’s first zero-carbon-emission prefilled autoinjector.” "We must take responsibility for ...
Astria Therapeutics has selected Ypsomed's Ypsomate autoinjector as its partner for the administration of STAR-0215 for the treatment of hereditary angioedema (HAE). US-based Astria's lead candidate, ...
BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (ATXS) (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results